Recent News

• 09.16.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
• 09.12.2025 - Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
• 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib at the IASLC 2025 World Conference on Lung Cancer
• 09.04.2025 - Cantor Global Healthcare Conference 2025

Recent Filings

• 09.04.2025 - 8-K Current report
• 09.04.2025 - EX-99.1 EX-99.1
• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.08.2025 - 3 Initial statement of beneficial ownership of securities
• 08.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.08.2025 - 3 Initial statement of beneficial ownership of securities
• 08.07.2025 - 8-K Current report
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]